Initial staging impact of fluorideoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer

Oncologist

Volumn 16, Issue 6, 2011, Pages 772-782

  Niikura, Naoki ^a,b   Liu, Jun ^a   Costelloe, Colleen M ^a   Palla, Shana L ^a   Madewell, John E ^a   Hayashi, Naoki ^a   Yu, Tse Kuan ^a   Tokuda, Yutaka ^b   Theriault, Richard L ^a   Hortobagyi, Gabriel N ^a   Ueno, Naoto T ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BONE SCINTISCANNING; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RELAPSE FREE SURVIVAL; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY;

ADULT; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATORY BREAST NEOPLASMS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79959583800     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-0378     Document Type: Article

References (20)

1. Hance KW, Anderson WF, Devesa SS et al. Trends in inflammatory breast carcinoma incidence and survival: The Surveillance, Epidemiology, and End Results program at the National Cancer Institute. J Natl Cancer Inst 2005;97:966-975.
2. Al-Husaini H, Amir E, Fitzgerald B et al. Prevalence of overt metastases in locally advanced breast cancer. Clin Oncol (R Coll Radiol) 2008;20:340-344.
3. Puglisi F, Follador A, Minisini AM et al. Baseline staging tests after a new diagnosis of breast cancer: Further evidence of their limited indications. Ann Oncol 2005;16:263-266.
4. Carlson RW, McCormick B. Update: NCCN breast cancer clinical practice guidelines. J Natl Compr Canc Netw 2005;3(suppl 1):S7-S11.
5. Fuster D, Duch J, Paredes P et al. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures. J Clin Oncol 2008;26:4746-4751.
6. Carkaci S, Macapinlac HA, Cristofanilli M et al. Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: Preliminary data. J Nucl Med 2009;50:231-238.
7. Alberini JL, Lerebours F, Wartski M et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer. Cancer 2009; 115:5038-5047.
8. Heusner TA, Kuemmel S, Umutlu L et al. Breast cancer staging in a single session: Whole-body PET/CT mammography. J Nucl Med 2008;49:1215-1222.
9. Groheux D, Moretti JL, Baillet G et al. Effect of (18)F-FDG PET/CT imaging in patients with clinical stage II and III breast cancer. Int J Radiat Oncol Biol Phys 2008;71:695-704.
10. Niikura N, Costelloe C, Madewell J et al. Role of FDG-PET/CT in meta-static staging of newly diagnosed primary breast cancer [abstract P5-01-02]. Presented at San Antonio Breast Cancer Symposium, San Antonio, TX, December 8-12, 2010.
11. Singletary SE, Allred C, Ashley P et al. Staging system for breast cancer: Revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am 2003;83:803-819.
12. Black MM, Speer FD. Nuclear structure in cancer tissues. Surg Gynecol Obstet 1957;105:97-102.
13. The World Health Organization. Histological typing of breast tumors. Neo-plasma 1983;30:113-123.
14. Buck AK, Herrmann K, Stargardt T et al. Economic evaluation of PET and PET/CT in oncology: Evidence and methodologic approaches. J Nucl Med 2010;51:401-412.
15. Ravaioli A, Pasini G, Polselli A et al. Staging of breast cancer: New recommended standard procedure. Breast Cancer Res Treat 2002;72: 53-60.
16. Myers RE, Johnston M, Pritchard K et al. Baseline staging tests in primary breast cancer: A practice guideline. CMAJ 2001;164:1439-1444.
17. Dillman RO, Chico S. Radiologic tests after a new diagnosis of breast cancer. Eff Clin Pract 2000;3:1-6.
18. Samant R, Ganguly P. Staging investigations in patients with breast cancer: The role of bone scans and liver imaging. Arch Surg 1999;134:551-553; discussion 554.
19. Gerber B, Seitz E, Miler H et al. Perioperative screening for meta-static disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread. Breast Cancer Res Treat 2003;82: 29-37.
20. Schneider C, Fehr MK, Steiner RA et al. Frequency and distribution pattern of distant metastases in breast cancer patients at the time of primary presentation. Arch Gynecol Obstet 2003;269:9-12.